Effect of diclofenac suppository on pain control during flexible cystoscopy-A randomized controlled trial.

TRIAL
DESIGN: To compare the difference in pain score during flexible cystoscopy between patients undergoing the procedure with plain lubricating gel  only and plain gel with diclofenac suppository in a randomized control trial.
METHODS:   A total of 60 male patients with an indication of flexible cystoscopy were enrolled in a prospective, randomized controlled study. Patients were randomized in two groups. In group "A", patients received diclofenac suppository one hour prior to the procedure while group "B" did not receive diclofenac suppository. Both groups received 10 ml of intra-urethral  plain gel for lubrication during flexible cystoscopy. Pain score was recorded immediately after the procedure using the visual analogue scale (VAS). Pre- and post-procedure pulse rate and systolic blood pressure was also recorded. Statistical analyses were performed using chi-square test and student t-test. Regression analysis was performed to address the confounding variables.
RESULTS: Both groups were comparable for variables including age, duration of procedure, level of operating surgeon and indication of procedure. Most common indication for flexible cystoscopy was removal of double J stent. There was a statistically significant difference in the mean pain score between two groups ( p = 0.012).  The difference in post-procedure mean pulse rate in the two groups was statistically significant ( p= 0.01) however there was no difference observed in mean post procedure systolic blood pressure. Regression analysis showed that none of the confounding variables were significantly affecting pain perception.
CONCLUSIONS: Intra rectal diclofenac suppository is simple and effective pre-emptive analgesia. We recommend its routine use during flexible cystoscopy for better pain control.

RCT Entities:   Population Interventions Outcomes

Introduction

The earliest reported use of flexible endoscope for examination of bladder neck was by Tsuchida and Sugawara [1]. It is now one of the most commonly performed diagnostic as well as therapeutic urologic interventions [2]. Pain associated with cystoscopy varies from patient to patient and there is continuous effort using various methods to reduce pain during and after the procedure to improve patient compliance for flexible cystoscopy. The majority of patients require local anesthesia or lubricant solution only but some patients may require intravenous sedation [3] or inhalation analgesia (nitrous oxide) [4]. Factors contributing to severity of pain include: lubrication, use of topical anesthesia and duration of cystoscopy [5– 7] but the available evidence for best practice in terms of treatment is continuously evolving [8]. The important issues regarding the correct use of intra-urethral gels are, for the most part, left to individual preference [9]. Effect of different intra-urethral gels, their dosage, temperature and time of instillation on pain perception has been evaluated in literature. In a randomized control trail, 2% lidocaine gel in two different doses (10 and 20 ml) and plain lubricating gels were found to be equally effective for pain control during flexible cystoscopy (p=0.406) [10]. Pain perception with use of lidocaine versus plain lubricating gel is less as reported in a meta-analysis by Aaronson et al. [11] while another meta-analysis by Patel et al. has reported no statistical difference among the two gels for pain control [12]. In a study by Komiya et al., oral zaltoprofen has been used as pre-emptive analgesia for rigid cystoscopy and it has been proved to provide better pain control than 2% lidocaine gel alone (11.35 versus 13.69 with a difference of pain score -2.8, p-value 0.0087) [13]. Intra-rectal diclofenac suppository administration used by Irer et al. has a proven role to reduce pain and improve patients’ tolerance of trans rectal ultrasound-guided prostate biopsy [14].

Diclofenac is an anti-inflammatory drug with local and systemic effects; the local effects include reducing the impact of pain mediators. The diclofenac suppository in comparison to the oral has a rapid onset and a slower rate of absorption. The maximal plasma level Is reached within 2 hours, and is maintained for up to 12 hours and that forms the basis of using suppository rather than oral NSAID in our study [15]. In the current study we have attempted to assess the use of diclofenac suppository as a pre-emptive analgesia during flexible ureteroscopy.

Methodology

Study protocol, patient recruitment and randomization

The Ethical Review Committee of the Aga Khan University and the Clinical Trial Unit approved the study protocol. The study was registered at www.clinicaltrials.gov (ClinicalTrials.gov identifier: NCT01812928). This trial was conducted at the surgical day care unit from February 2013 to July 2013.

Details of recruitment and flow of study has been demonstrated as CONSORT flow diagram. ( Figure 1). The principal investigator of this study obtained the written consent from all the qualified patients before randomization. All male patients of 18 years of age and older with indication for flexible cystoscopy, were assessed for recruitment in the trial. We included all adult males who attended for evaluation of hematuria or lower urinary tract symptoms and those for removal of double J ureteral stent. All patients undergoing the procedure had a urinalysis and culture to exclude UTI. Patients were requested to empty the bladder immediately prior to the procedure or within 30 minutes. Prior to the procedure, patients were explained the visual analog scale (VAS; score zero means no pain and 10 means worst pain). Eligible patients were randomized by a computer-generated list and sealed envelopes. Patients were randomized into either Group A (those patients who received diclofenac suppository prior to procedure) or Group B (those patients who did not receive diclofenac suppository prior to procedure) using a web-based random number generator (RANDOM.ORG, Dublin, Ireland; https://www.random.org). Diclofenac suppository (100 mg) was administered rectally 1 hour prior to the procedure in the pre-operative area. Both groups received 10 ml of plain lubricating gel immediately before the procedure for the purpose of lubrication.

Figure 1.

CONSORT statement describing the details eligibility, allocation, follow up and analysis of the patients.

The procedure was performed at the surgical day care unit in supine position by a consultant urologist or senior urology resident (residency year 5 and 6) that was blinded to the randomization group. A second resident immediately following the procedure, collected data (pain score) in the operating room. The VAS consists of a straight line with the endpoints defining extreme limits such as ‘no pain at all’ and ‘pain as bad as it could be’ [16]. The investigator was blinded to the group (independent assessor). Operative time was recorded from the operating room time log. Pre- and post-procedure pulse rate and blood pressure were recorded for all participants.

Data analysis

Data was analyzed using SPSS™ version 17.0. Results were described in terms of mean and standard deviation for age, duration of procedure and pain score while frequency and percentage were mentioned for categorical variables. The student t-test (independent samples, one-tailed) was used to determine statistical significance of VAS for pain between group A and B. Confounder and effect modifiers i.e. age, level of the person performing procedure, indication for procedure and duration of procedure were analyzed using linear regression analysis. p-value of <0.05 was considered as statistically significant.

Group A: Diclofenac + Gel; Group B: Gel alone; Indication: 1= LUTS, 2= Haematuria, 3= JJ Stent removal.

Click here for additional data file.

Results

Seventy-three patients were evaluated for inclusion in the study. A total of sixty patients were recruited in the trial and analyzed. The mean age was 46.75 ± 16.12 years (IQR: 18–80). The most common indication for flexible cystoscopy was removal of double J Stent (n= 38, 63.3%), others were for evaluation of hematuria (16, 26.7%) and lower urinary tract symptoms (6, 10%). Year 5 and 6 urology residents performed the majority of the procedures (n= 56). Mean duration of the procedure was 5.52 ± 2.13 minutes (IQR: 2–10 minutes). On the 11 point VAS the mean pain score was 3.63 with a standard deviation of 1.46 for the entire group (IQR: 0 – 7). The highest pain score was of 7 on VAS reported by only one patient from group B.

The mean age of the patients in groups A and group B were 48.53 ± 17.81 years and 44.97 ± 14.31 years respectively and there was no statistically significant difference ( p= 0.53). The pre-procedure pulse and systolic blood pressures were comparable in both groups. Mean duration of procedure in group A was 5.76 ± 2.25 minutes and in group B was 5.28 ± 2.00 minutes. This difference in duration was not statistically significant ( p=0.82). Indications for the procedure and level of operating surgeon were also comparable between the groups.

Mean pain score in group A was 3.16 ± 1.53 and in group B was 4.10 ± 1.24. This difference in the mean pain score was found to be statistically significant ( p= 0.012). None of our patients required additional analgesia in either group. The difference in post-procedure pulse rate was found to be statistically significant ( p=0.01) between groups however no statistically significant difference ( p=0.15) was observed in systolic blood pressure between two groups ( Table 1).

Table 1.

Basic demographic profile of the patients in the two groups.

Parameters	Group A	Group B	p value
Age (years) Mean ± SD	48.53 ± 17.8	44.97 ± 14.3	0.53
Duration (min) Mean ± SD	5.76 ± 2,25	5.28 ± 2.0	0.82
Indications
JJ stent removal	17	21
Evaluation of hematuria	10	6	0.497
Evaluation of LUTS	3	3
Level of operating surgeon
Consultant urologist	2	2
Senior urology resident	28	28	0.694
Post-procedural pulse/min Mean ± SD	73.5 ± 4.1	76.4 ± 3.8	0.01
Post-procedural systolic pressure Mean ± SD	129.3	130.1	0.15
Pain score on VAS Mean ± SD	3.16 ± 1.53	4.10 ± 1,24	0.012

Linear regression analysis was performed. None of the confounding factors (including age, indication for procedure, level of operating surgeon and duration of procedure) was found to have significant impact on the outcome parameter (r 2 = 0.026, standard error of estimate= 1.479; Table 2).

Table 2.

Multiple linear regression analysis of factors associated with pain.

Model summary (a) 

Model	R	R square	Adjusted R square	Std error of the estimate
1	0.163 [*]	0.026	-0.026	1.47961

* Predictor: (constant), indication for procedure

Discussion

We examined the effect of pre-emptive analgesia on pain perception during flexible cystoscopy and found out that diclofenac suppository significantly reduces pain when administered as pre-emptive analgesia before flexible cystoscopy.

Randomized studies by Patel et al. [12] regarding use of lidocaine versus plain gel, which included 817 patients, showed that intra urethral lidocaine gel had no statistical effect on pain on a 100-point VAS scale (95% CI, -9.6 to 0.385). This meta-analysis challenged the commonly held belief among clinicians that intra urethral lidocaine gel is more efficacious than plain gel for decreasing pain during flexible cystoscopy [12]. In contrast to the findings of Patel et al. [12], Cornel et al. observed slightly less pain (statistically non significant) in the test group and pain perception was the same between patients with past experience of cystoscopy and initial cystoscopy [17]. To avoid this bias, we kept very strict inclusion criteria and excluded all the patients with previous experience of flexible cystoscopy.

The present study has demonstrated significant reduction in pain perception during flexible cystoscopy in male patients with use of diclofenac suppository as pre-emptive analgesia. Sample size was calculated a priori to detect the effect, according to Lwanga et al. [18] We followed stringent criteria for enrollment of patients in this trial to eliminate confounding factors for pain. Computer generated sequences were used for randomization in order to give equal chance of being selected in either group to all recruited patients.

Flexible cystoscopy is often performed repeatedly in particular during the follow up of urothelial cancer. As repeated cystoscopy did not increase the patient's tolerability to pain associated with cystoscopy, Muezzinoglu noted the need for more effective anesthesia to improve tolerability during the procedure and maintain quality of life of the patients under long-term follow-up with repeated cystoscopies [19]. Till date various techniques have been used to ameliorate the perception of pain during flexible cystoscopy. Use of NSAID as pre-emptive analgesia has been tested for various surgical procedures [20, 21]. Komiya and co-workers examined the effect of anti-inflammatory drug (NSAID) zaltoprofen that inhibits the generation of prostaglandins as well as the pain induced by bradykinin during rigid cystoscopy [13]. The mean age of the patients in their study was 69.3+/- 8.2 (range: 41–83) while in our study we had relatively younger study subjects (mean age+/- SD, range: 46.75+/-16.1 years, 18–80 years) who are presumably more anxious with lower pain threshold. Despite this fact, diclofenac suppository significantly improved the pain perception and proved to be effective regardless of age on regression analysis. Another matter of debate is the statistical method used in the study by Komiya et al. [13] where they used a “one sample Wilcoxon test” for comparing the two groups which is rather an inappropriate test to demonstrate the effect. The one-Sample Wilcoxon signed-rank test is a non-parametric alternative to a one-sample t-test. The test determines whether the median of the sample is equal to some specified value. Data should be distributed symmetrically about the median. In the present study we have used regression analysis, which is a more stringent method to demonstrate the effect.

In our study, we used diclofenac suppository as pre-emptive analgesia. The pharmacokinetics of the suppository form is quite different from the orally administered agent. It acts as an anti-inflammatory drug both locally and systemically, by minimizing the effects of local mediators involved in the pain response. Diclofenac has been marketed internationally since 1973 and is currently available in oral, rectal, parenteral and topical preparations [15]. The efficacy of the diclofenac suppository is due to more rapid onset of effect, and a slower rate of absorption (it takes approximately 4.5 hours for complete absorption) than oral enteric-coated tablets. The maximal plasma level is attained within 2 hours, and it is maintained for up to 12 hours [15]. The terminal half-life of diclofenac in plasma is 1 to 2 hours. The major route of excretion is the urine (~60%) and a small percentage through bile in the feces [22]. Its role has proven to be effective for pain control during trans rectal ultra sound guided prostate biopsy in study by Haq et al. [23]. In a case control the investigators noted that it is a simple and safe method. While Irer et al. [14] showed additional benefit of using lidocaine gel for pain control during the same procedure but statistical significance of this study is in question due to its smaller sample size.

In the present study, appropriate sample size, stringent criteria for recruitment, computer generated randomization, proper statistical methods and analysis has increased the scientific rigor. This was not a placebo controlled as various per rectally medications or “dummy drugs” may have some local inflammatory effect.

Conclusion

Intra rectal diclofenac suppository is a simple and effective method to reduce pain during flexible cystoscopy regardless of age. We recommend its routine use for better tolerability of pain and to increase patient’s compliance.

Data availability

The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2016 Nadeem M and Ather MH

Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

F1000Research: Dataset 1. Raw data for ‘Effect of diclofenac suppository on pain control during flexible cystoscopy-A randomized controlled trial’, 2016, 10.5256/f1000research.9519.d145268 [24]

Usage of diclofenac suppository, seems to be an excellent choice, based on the results of this revelatory research, so I congratulate the authors for running a well-designed trial and obtained an acceptable scientific standard.

The issue of non-anesthetists procedures, for any examination like flexible cystoscopy, is always the most common matter of concern about patients for the practicing Urologists. Worldwide there are many used local anesthetic drugs or substitutes transient analgesia, without much success in the best case or side effects to their use in the worst. However, the use of an analgesic which may be readily obtained from the patient while avoiding adverse effects associated with the gastric tolerability, for maintaining a sufficiently efficient to meet the requirements as a pain reliever during flexible cystoscopy, is not only necessary but also imperative. We will certainly take into account the fact that during both rigid and flexible cystoscopy, there is a potential of greater momentary discomfort when the stent is being pulled through the bladder neck and due to the length of the urethra. So, an effective analgesic, not only will help the patient to be well tolerated, it will give the advantage to the urologist to deal with more calm the cystoscopy.

Moreover it would be interesting to know the authors’ feedback on the response of patients according to sex and age in the administration of diclofenac.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

K Das and N Buchholz: Comment on “Nadeem M and Ather MH. Effect of diclofenac suppository on pain control during flexible cystoscopy-A randomized controlled trial [version 1; referees: awaiting peer review]. F1000Research 2016, 5:2834 (doi: 10.12688/f1000research.9519.1)”

Firstly, I congratulate the authors for a well-chosen study topic, and running a well-designed trial. Flexible cystoscopy, being a commonly practised office procedure without the involvement of anesthetists on most occasions, the choice of appropriate analgesics always remains a dilemma to the practising urologist. A gamut of approaches ranging from local anaethetic usage, lubricant solution to usage of inhalational agents has been practiced with mixed reports. Usage of diclofenac suppository, as has been advocated in this study appears to be a simple and effective approach for conducting this procedure. The statistics supports the claim of the proponents regarding the efficacy of this drug. Considering the ease of administration it will be a good option for the practising urologist conducting office flexible cystoscopy.

It would be interesting to know the authors’ feedback on the following aspects from their experience in this study-

Was there a difference in pain perception in individuals undergoing diagnostic flexible cystoscopy and those undergoing flexible cystoscopy for stent removal as the latter often involves added pain stimulus to the patient due to additional instrumentation.

Was the benefit of diclofenac suppository equally perceived in males and females - our personal observations are flexible cystoscopies are presumably easier and well tolerated in females than males.

The last sentence in the introduction says- “In the current study we have attempted to assess the use of diclofenac suppository as a pre-emptive analgesia during flexible ureteroscopy” - we presume this is a typographical error and should be “flexible cystoscopy” instead of flexible ureteroscopy – this needs to be corrected if so.

We have read this submission. We believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

We thank Drs. Buccholz and Das for their valuable comments on the above submission. In response to the questions raised:

No we did not find any difference in the diagnostic cystoscopy versus interventional flexicystoscopy(JJ stent removal). The subgroup analysis not shared in the data (as the numbers were small) was insignificant, however, our own experience was that there is indeed is a momentary discomfort when the stent is being pulled through the bladder neck.

Again an important point as indeed due to the length of the urethra there is a potential of greater discomfort in men during flexible cystoscopy. We, however, notice no significant difference in our practice (perhaps due to routine use of low pressure irrigation during introduction of the scope to keep the urethra open.) However, in our current work we only studied men.

Indeed it is a typographical error, many thanks for pointing this out.

Duration of procedure (b) 

	Coefficients*
Model	Unstandardized coefficient		Standardized coefficient	t	Sig	95% CI for B
	B	Std. Error	Beta			Lower bound	Upper Bound
1 (constant)	4.548	1.055		4.301		2.434	6.662
Group	-0.251	0.387	-0.086	-0.647	0.520	-1.027	0.526
Duration of procedure	-0.101	0.096	-0.147	-1.048	0.299	-0.293	0.092
Indication for procedure	0.007	0.233	0.004	0.032	0.975	-0.460	0.475